Sansert
Active Ingredient(s): MethysergideFDA Approved: * February 12, 1962
Pharm Company: * NOVARTIS
Category: Migraine / Tension Headache
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Sansert Overview
Methysergide (1-methyl-D-lysergic acid butanolamide or UML-491) also known as methysergide maleate, is an ergot derived prescription drug used for the prophylaxis of difficult to treat migraine and cluster headaches. Methysergide is no longer recommended as a first line treatment protocol by international headache societies, hospitals, and neurologists in private practice, for migraines or cluster headaches as side effects were first reported with long-term use in the late 1960s, and ergot ba...
Read more Sansert DetailsDetails May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Methysergide
Recent Sansert Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Methysergide
- Tablet: 2mg
NDC Database Records for Sansert: (1 result)
Sorted by National Drug Code- 0078-0058 Sansert 2 mg Oral Tablet by Novartis Pharmaceuticals Corporation
Other drugs which contain Methysergide or a similar ingredient: (1 result)
Related Sansert Topics:
Hope for getting Deseril/Sansert back?
I have been taking Sansert, later called Deseril in the U.K., and had almost none of the chronic daily migraines I had b... 1 reply
I have been taking Sansert, later called Deseril in the U.K., and had almost none of the chronic daily migraines I had b... 1 reply